Articles in section Research & Development
| << Opinion & Analysis | 470 articles | Royalties >> |
| Pages 1 2 3 4 5 .. 47 | Next >> |
-
Lilly Signs US$8.85 B Oncology and Immunology Partnership with Innovent Biologics
-
AstraZeneca Signs US$18.5 B Licensing Pact with CSPC Pharmaceutical Group for Obesity and Type 2 Diabetes Treatments
-
Lilly Signs US$1.9 B Global Collaboration with Repertoire for Autoimmune Diseases
-
Boehringer Ingelheim and Simcere Forge US$1.26 B Collaboration to Advance Inflammatory Bowel Disease Bispecific Antibody
-
Lilly and Nimbus Forge US$1.3 B Collaboration to Develop Oral Obesity Treatment
-
Merck KGaA Partners with Valo Health in US$3 B AI-Driven Neurology Collaboration
-
ModeX Therapeutics and Regeneron Collaborate to Develop Multispecific Antibodies for USS$1 B
-
Takeda Signs US$11.4 B Oncology Partnership with Innovent Biologics
-
Novartis Signs US$2.2 B Deal with Arrowhead Pharmaceuticals for RNAi Therapy
-
Lilly Signs US$856 M Licensing Pact with Gate Bioscience to Develop Molecular Gate Therapeutics
RSS